the father but not the mother; there was expression of only one pair of paternal A and B antigens, again pointing to likely origin from a single sperm. They suggested that hydatidiform moles resulted from "fertilisation" by a haploid sperm which subsequently duplicated its own chromosomes after meiosis; had a diploid sperm been produced at meiotic level HLA expression would probably have occurred for both paternal A and B antigen pairs in at least some cases.
Both polymorphic C-band features of chromosomes and HLA gene loci are, however, close to the centromere and therefore relatively inefficient markers for showing "cross-over." Lawler et a14 reported further evidence supporting the haploid sperm origin using five enzyme markers in 11 complete moles. More recently Jacobs's group in Hawaii have reported studies6 of phosphoglucomutase genotypes as well as chromosome banding in 20 moles and the parents concerned. Phosphoglucomutase is a better marker than HLA type since the gene responsible is probably more than five times further from the chromosome centromere than the HLA locus; again this study confirmed that in most cases the mole appears to arise from a haploid sperm.
Jacobs et a16 found two "atypical" moles among the 24 they karyotyped. One was 46,XX but with evidence of normal maternal and paternal haploid contributions, while another was 46,XY, but its origin could not be determined. Apparently while most moles are male derived ("androgenetic") there are a few in which other explanations must be sought.
There is another part to the mystery: the loss ofthe maternal haploid contribution, and on this there are few clues. It is beyond biological credulity that no chromosomes are present at completion of the maturation of the ovum. They may either be lost before or at the time of "fertilisation" or be driven out by the double male sets before the first mitotic cell division. There is some evidence that mothers who have molar pregnancies have an increased incidence of reciprocal translocations,' and such structural abnormalities may possibly be responsible for the ovum nucleus failing to persist.
All these remarks apply to the common type of complete mole; but hydatidiform moles are now usually divided into two types7: in complete (or classical) moles the conceptus consists of hydropic, hyperplastic villous tissue but no fetus is present, the usual chromosome complement being 46,XX with two sets of identical paternal haplotypes; in partial moles there is focal trophoblastic hyperplasia and a range of dropsical villi, associated with the presence of a fetus. For some considerable time partial moles have been known to be associated with chromosome abnormalities-particularly the presence of an extra set of chromosomes-triploidy (69,XXX or XXY).
The source of the extra chromosome set in the triploid incomplete moles was found to be male in three out of three cases studied, but the paternal haploid sets were not identical. In two instances the evidence pointed to double fertilisation (dispermy), while the third could have been due to dispermy or failure of the first paternal meiotic division.4 Both types of moles, therefore, seem often to have an extra set of paternal chromosomes-identical in the complete type and non-identical in the partial form. Not by any means all triploid conceptuses develop into partial moles-they often terminate as early spontaneous abortions4-while initial reports of dispermic conceptions concerned intersexual (46,XX/46,XY) chimeras.8 While the complete moles have no mother in a chromosomal sense, the dispermic partial moles could possibly have two fathers, given maternal promiscuity.
These remarkable discoveries are important far beyond the field ofreproductive biology. Trophoblastic neoplasia, ofwhich hydatidiform mole can be regarded as the simple but premalignant form, is still a major problem in many parts of the world despite advances in chemotherapy, and these new discoveries may prove important. The risk of a mole undergoing transformation to chorionic carcinoma9 is greater in the complete than the partial variety, but there is not sufficient evidence at present to say malignancy may not develop with partial forms. The new knowledge is also likely to be relevant to the well-known propensity for pre-eclampsia to develop in association with hydatidiform mole, and it may provide important clues in the tantalisingly difficult task of elucidating the cause of pre-eclampsia. A theological student who turns his attention to this information must get ample food for thought, while a jurist specialising in parentage cases could find much material calculated to astonish the judges. Over the past 10 years infection has remained the main cause of illness and mortality among patients with acute leukaemia being treated with chemotherapy. The lungs are the single most common site of infection during both the induction of remission and maintenance treatment. 16 Pneumonia occurs in about one-third of all adults during treatment, but until recently the rate in children was only 5%/. I27 A report this year on a group of children with acute lymphoblastic leukaemia has suggested that with the addition of methotrexate and the intensification of treatment regimens the rate is now higher: 28% of children were affected.8 Nevertheless, a causative organism was isolated in only 20 % of these cases; this difficulty in diagnosis, together with the inclusion of a large number of cases of pneumocystis pneumonia occurring in the second month of treatment, make the increase difficult to interpret.
In adults the incidence of infection increases with the degree of neutropenia, which is itself principally related to the intensity of the chemotherapy.15 In patients with severe neutropenia the usual clinical presentation-the production of sputum and radiological signs of pneumonia-may be completely abolished, though these signs may return as the circulating neutrophil count recovers.4 910 This impairment of the normal response of the lungs to infection makes interpretation of diffuse lung shadows in a chest radiograph of a feverish patient with neutropenia a common diagnostic problem.
Even with repeated culturing of samples of blood and sputum and serological testing an organism will be identified in less than a third of all cases.' 10 Direct sampling from the
